Calidi Biotherapeutics
San Diego
About Calidi Biotherapeutics
Calidi Biotherapeutics is a company that creates oncolytic virus-based immunotherapies to treat difficult-to-treat malignancies. The company focuses in immunotherapies developed using patented technology for the effective delivery of oncolytic viruses for targeted therapy, allowing healthcare practitioners to provide patients with innovative cancer treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $101.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2026)
- Ticker: nysemkt:CLDI
- Website: calidibio.com
- Phone: +1 858 794-9600
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/calidi-biotherapeutics-19534 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.